Sunlight and Mitochondria: Three Mechanisms That Exercise Alone Doesn't Cover

A 2026 study from the University of Colorado Anschutz Medical Campus measured mitochondrial function directly — muscle biopsies, high-resolution respirometry — in healthy but sedentary adults versus regularly active controls (San Millán et al., Clinical Bioenergetics, DOI: 10.3390/clinbioenerg2030010). The findings were stark: sedentary individuals showed 28–36% lower activity across all four mitochondrial electron transport chain complexes (I–IV), 49% lower MPC1 protein (which carries pyruvate into mitochondria), and approximately 50% lower CPT1 enzyme activity (fat oxidation capacity).

This wasn't a study of sick people. These were healthy, non-obese, non-smoking adults. The mitochondrial impairment was a consequence of not moving.

Exercise is the right primary response — aerobic training demonstrably restores mitochondrial biogenesis and ETC function. But the San Millán data opens a parallel question the sedentary-mitochondria literature has not asked: does sunlight exposure add anything to mitochondrial health beyond what exercise provides?

Based on three distinct mechanisms, the answer appears to be yes — though the human evidence varies by pathway from solid to speculative, and we label each accordingly.

The falsifiable prediction: a head-to-head trial of outdoor versus matched- intensity indoor exercise with skeletal muscle biopsies and high-resolution respirometry as primary endpoints would directly test whether solar exposure provides additive mitochondrial benefit. If outdoor and indoor exercise produce equivalent respirometry outcomes, the three mechanisms below contribute nothing additive. That trial has not been run.

Mechanism 1: Red/NIR light directly activates Complex IV

Cytochrome c oxidase (CcO), the terminal enzyme of the mitochondrial electron transport chain (Complex IV), is a photoreceptor. It has two distinct light absorption peaks: approximately 620–680nm (red) and 760–895nm (near-infrared). Photon absorption by CcO dissociates inhibitory nitric oxide (NO) from the enzyme's active site, restoring electron transfer and increasing oxygen consumption and ATP output.

This is photochemistry, not a wellness claim. The mechanism was characterized by Tiina Karu's group beginning in the 1980s and has been independently replicated in isolated mitochondria, cell culture, and animal models. Primary human-level evidence comes from photobiomodulation (PBM) device studies:

• A 2022 study in Journal of Biophotonics (Gkotsi, Begum, Powner et al., doi:10.1002/jbio.202200096) found that 670nm light protected cytochrome c oxidase activity and enhanced glucose uptake in retinal photoreceptor cell cultures and an aged mouse model — connecting light-driven CcO activation to the same fuel-switching machinery (pyruvate/glucose entry into mitochondria) that the CU Anschutz study found impaired in sedentary adults. The paper also notes complex mixed effects including altered mitochondrial dynamics; human in vivo replication has not been done
• A 2025 UCL study in Scientific Reports (Powner & Jeffery, doi:10.1038/s41598-025-88129-3) demonstrated that NIR light between 800–900nm (peak transmission ~850nm) measurably passes through the human thorax in living volunteers — confirmed via a swallowed spectrophotometer capsule in 10 participants. The transmitted fraction is extremely small (~1×10⁻⁹ of input photons) but statistically significant, raising the possibility of systemic mitochondrial effects from non-local NIR exposure
• Cross-species conservation: PBM effects on mitochondria are documented in Drosophila and mice with aging-relevant outcomes, strengthening mechanistic plausibility

Critical calibration: The CcO mechanism is solid in vitro and at therapeutic device doses. Whether ambient solar NIR, at the doses reaching skeletal muscle mitochondria through skin and tissue, is sufficient to produce meaningful CcO activation in humans under real-world conditions is plausible but not directly demonstrated. The difference between device protocols and ambient solar exposure matters and should not be glossed over.

Mechanism 2: UV-B → Vitamin D3 → Mitochondrial Biogenesis

The CU Anschutz study found impaired biogenesis markers — reduced MPC1 and CPT1 — suggesting not just functional decline but structural mitochondrial loss. Vitamin D, synthesized in skin from UV-B exposure, is an upstream regulator of mitochondrial biogenesis.

The molecular pathway: UV-B → cholecalciferol (vitamin D3) in skin → hepatic 25-hydroxylation → renal 1α-hydroxylation → calcitriol (active form) → vitamin D receptor (VDR) activation → PGC-1α and TFAM upregulation → mitochondrial biogenesis.

Human evidence: Ryan et al. (Nutrients 2022, PMID 35143698) demonstrated dose-dependent PGC-1α and TFAM upregulation by vitamin D3 in skeletal muscle cells, with increased mitochondrial content, OXPHOS capacity, and ATP production. VDR has also been found in the mitochondrial compartment itself — suggesting direct organelle-level signaling beyond nuclear receptor pathways (PMC10860740).

Qualification: Evidence is strongest in vitamin D-deficient populations — correction of deficiency drives the most robust biogenesis effects. Whether sun-derived D3 meaningfully drives biogenesis in already D3-replete individuals is less clear. The full pathway from UV-B to calcitriol to muscle PGC-1α involves multiple rate-limiting steps that vary by age, BMI, and kidney function.

Mechanism 3: Morning Sunlight → BMAL1 → Gated OXPHOS Efficiency

Mitochondria are not just machines — they are temporally regulated machines. BMAL1, the core positive transcriptional regulator of the circadian clock, controls:

• ATP synthesis efficiency across 24-hour cycles (Neufeld-Cohen et al., PNAS 2016)
• Mitochondrial biogenesis via PGC-1α transcriptional control (Gong et al., Redox Biology 2019)
• Mitochondrial fission-fusion dynamics and morphology (Schmitt et al., Cell Reports 2018)

BMAL1 knockout in muscle-specific mouse models produces significantly impaired mitochondrial respiratory capacity and OXPHOS. Disrupted circadian rhythm disrupts mitochondrial function — restoring circadian alignment should improve mitochondrial performance.

Morning outdoor light is the dominant natural zeitgeber for circadian alignment. The pathway: retinal melanopsin (480nm) → SCN → systemic cortisol/melatonin timing → peripheral BMAL1 rhythms in muscle → gated PGC-1α expression → mitochondrial biogenesis and OXPHOS efficiency.

Qualification: The BMAL1-to-mitochondria link is robustly established in rodent models. Human evidence is primarily observational (shift workers with chronically disrupted clocks show metabolic dysfunction concordant with mitochondrial impairment) but confounders are substantial. The chain from morning light behavior to muscle mitochondrial outcomes has not been directly tested in a controlled human study.

The connection to the CU Anschutz findings

The San Millán study found sedentary adults mitochondrially impaired across all four complexes — with the most severe losses in Complex I and Complex IV. Complex IV is precisely the CcO photoreceptor targeted by red/NIR light. The mitochondria that sedentary behavior degrades most are the ones most directly activated by solar wavelengths. The study also found impaired fuel entry (MPC1/CPT1 down ~50%) — the same glucose transport machinery that Powner et al. found improved by 670nm photostimulation.

An honest summary

Community question: Is any group currently designing or running a study comparing outdoor versus indoor exercise with direct mitochondrial outcomes as the endpoint? Or using wearable UV/NIR dosimetry alongside metabolic testing? This is the natural follow-on to the San Millán cohort — we'd like to connect with anyone working on it.